Antibody fragments as tools in crystallography
- PMID: 21649648
- PMCID: PMC3170977
- DOI: 10.1111/j.1365-2249.2011.04427.x
Antibody fragments as tools in crystallography
Abstract
While antibody-based therapeutics have become firmly established as front-line drugs, the use of antibodies as research tools in small molecule drug discovery is still in its infancy. In this review we focus on the use of antibody fragments as crystallization chaperones to aid the structural determination of otherwise 'uncrystallizable' or 'undruggable' target proteins. We also highlight a potential application for this technology, in which antibody-mediated structures may be used to inform the design of new chemical entities.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.
References
-
- Jhoti H. Fragment-based drug discovery using rational design. Ernst Schering Found Symp Proc. 2007;3:169–85. - PubMed
-
- Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov. 2007;6:211–19. - PubMed
-
- Derewenda ZS. The use of recombinant methods and molecular engineering in protein crystallization. Methods. 2004;34:354–63. - PubMed
-
- Hunte C, Michel H. Crystallisation of membrane proteins mediated by antibody fragments. Curr Opin Struct Biol. 2002;12:503–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
